ROP: Lower dose of intravitreal bevacizumab performs as effectively as higher dose
Ophthalmology Times Europe,
Reviewed by Dr Thomas Wayne Hejkal. A 30-mcg intravitreal dose of bevacizumab (Avastin, Genentech, Inc.) is as effective as 20…
A Dosing Study of Bevacizumab for Retinopathy of Prematurity Late Recurrences and Additional Treatments
Overview of attention for article published in Ophthalmology, June 2018
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (86th percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Mentioned by
- news
- 1 news outlet
- 8 X users
- 1 Facebook page
- f1000
- 1 research highlight platform
Readers on
- mendeley
- 103 Mendeley